Thai health authorities approve Sinovac, Sinopharm vaccines for use in children
BANGKOK, Feb. 4 (Xinhua) -- Thailand's Food and Drug Administration (FDA) said Friday that it has approved the use of China's Sinovac and Sinopharm COVID-19 vaccines for people 6 years of age and older.
Previously, the FDA only permitted the two vaccines to be used on people aged 18 and above.
The FDA announcement came as the Southeast Asian country has been accelerating vaccine roll-out to step up protection against COVID-19.
On Friday, the country reported 9,909 new confirmed cases during the last 24 hours, the highest daily case tally in more than three months, raising the total number of infections to over 2.47 million, according to the Center for COVID-19 Situation Administration (CCSA).
As of Thursday, 70.1 percent of the country's nearly 70-million population had been fully vaccinated, while 21.4 percent had received booster shots, according to the CCSA.
In December 2021, Thailand's FDA gave the green light to allow children aged 5 to 11 to receive the Pfizer COVID-19 vaccine.
Photos
Related Stories
- China's Sinovac to support Egypt with fully-automated cooling facility for vaccine storage
- China to donate two mln doses Sinovac vaccines to Botswana
- China to donate another 1 mln Sinovac vaccines to Malaysia
- UK to add China's Sinovac, Sinopharm to approved vaccine list
- Philippines receives more Sinovac vaccines from China
- Sinovac launches clinical trial of COVID-19 vaccine on children, teenagers in South Africa
- El Salvador receives new batch of COVID-19 vaccines from Chinese pharmaceutical company Sinovac
- S. African minister welcomes approval of China's Sinovac COVID-19 vaccine by SAHPRA
- Sinovac vaccine 'well tolerated, safe and induced humoral responses' in minors aged 3-17, to boost public confidence on herd immunity
- Sinovac vaccine cuts COVID-19 deaths among Uruguayan adults by 95 pct: study
Copyright © 2022 People's Daily Online. All Rights Reserved.